1. Market Research
  2. > Dongwha Pharm Co., Ltd. - Product Pipeline Review - 2013

Dongwha Pharm Co., Ltd. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 30 pages

Dongwha Pharm Co., Ltd. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Dongwha Pharm Co., Ltd. - Product Pipeline Review - 2013” provides data on the Dongwha Pharm Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Dongwha Pharm Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Dongwha Pharm Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Dongwha Pharm Co., Ltd. - Brief Dongwha Pharm Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Dongwha Pharm Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Dongwha Pharm Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Dongwha Pharm Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Dongwha Pharm Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Dongwha Pharm Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Dongwha Pharm Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Dongwha Pharm Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Dongwha Pharm Co., Ltd. and identify potential opportunities in those areas.

Table Of Contents

Dongwha Pharm Co., Ltd. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Dongwha Pharm Co., Ltd. Snapshot 5
Dongwha Pharm Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Dongwha Pharm Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Dongwha Pharm Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Dongwha Pharm Co., Ltd. - Pipeline Products Glance 10
Dongwha Pharm Co., Ltd. - Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
Dongwha Pharm Co., Ltd. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Dongwha Pharm Co., Ltd. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Dongwha Pharm Co., Ltd. - Drug Profiles 15
Drug For Stroke 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
DW-1006 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
DW-1029M 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
DW-1350 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
DW-167 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
zabofloxacin 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Dongwha Pharm Co., Ltd. - Pipeline Analysis 21
Dongwha Pharm Co., Ltd. - Pipeline Products by Therapeutic Class 21
Dongwha Pharm Co., Ltd. - Pipeline Products By Target 23
Dongwha Pharm Co., Ltd. - Pipeline Products by Route of Administration 24
Dongwha Pharm Co., Ltd. - Pipeline Products By Mechanism of Action 25
Dongwha Pharm Co., Ltd. - Dormant Projects 26
Dongwha Pharm Co., Ltd. - Locations And Subsidiaries 27
Head Office 27
Other Locations and Subsidiaries 27
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30

List of Tables

Dongwha Pharm Co., Ltd., Key Information 5
Dongwha Pharm Co., Ltd., Key Facts 5
Dongwha Pharm Co., Ltd. - Pipeline by Indication, 2013 7
Dongwha Pharm Co., Ltd. - Pipeline by Stage of Development, 2013 8
Dongwha Pharm Co., Ltd. - Monotherapy Products in Pipeline, 2013 9
Dongwha Pharm Co., Ltd. - Phase III, 2013 10
Dongwha Pharm Co., Ltd. - Phase II, 2013 11
Dongwha Pharm Co., Ltd. - Phase I, 2013 12
Dongwha Pharm Co., Ltd. - Preclinical, 2013 13
Dongwha Pharm Co., Ltd. - Discovery, 2013 14
Dongwha Pharm Co., Ltd. - Pipeline By Therapeutic Class, 2013 22
Dongwha Pharm Co., Ltd. - Pipeline By Target, 2013 23
Dongwha Pharm Co., Ltd. - Pipeline By Route of Administration, 2013 24
Dongwha Pharm Co., Ltd. - Pipeline Products By Mechanism of Action, 2013 25
Dongwha Pharm Co., Ltd. - Dormant Developmental Projects,2013 26
Dongwha Pharm Co., Ltd., Other Locations 27

List of Figures

Dongwha Pharm Co., Ltd. - Pipeline by Indication, 2013 7
Dongwha Pharm Co., Ltd. - Pipeline by Stage of Development, 2013 8
Dongwha Pharm Co., Ltd. - Monotherapy Products in Pipeline, 2013 9
Dongwha Pharm Co., Ltd. - Pipeline By Therapeutic Class, 2013 21
Dongwha Pharm Co., Ltd. - Pipeline By Route of Administration, 2013 24
Dongwha Pharm Co., Ltd. - Pipeline Products By Mechanism of Action, 2013 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.